Stanislas Mayer

Person

Eschau, FR

People

Patents Grantslast 30 patents

Information Patent Grant
5-azaindazole derivatives as adenosine receptor antagonists
- Patent number 12,194,051
- Issue date Jan 14, 2025
- Merck Patent GmbH
- Anne-Laure Blayo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted heterocyclic compounds as allosteric modulators of grou...
- Patent number 11,472,806
- Issue date Oct 18, 2022
- DOMAIN THERAPEUTICS
- Anne-Laure Blayo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteri...
- Patent number 11,008,323
- Issue date May 18, 2021
- DOMAIN THERAPEUTICS
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as all...
- Patent number 10,221,179
- Issue date Mar 5, 2019
- DOMAIN THERAPEUTICS
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as all...
- Patent number 9,434,734
- Issue date Sep 6, 2016
- DOMAIN THERAPEUTICS
- Stanislas Mayer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adenosine receptor ligands and uses thereof
- Patent number 9,029,393
- Issue date May 12, 2015
- Kaldi Pharma, SAS
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxime derivatives and their use as allosteric modulators of metabot...
- Patent number 8,962,627
- Issue date Feb 24, 2015
- Prestwick Chemical, Inc.
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Partial and full agonists of A1 adenosine receptors
- Patent number 7,300,923
- Issue date Nov 27, 2007
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20250049814
- Publication date Feb 13, 2025
- Merck Patent GmbH
- Anne-Laure BLAYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PAR-2 INHIBITORS
- Publication number 20240066027
- Publication date Feb 29, 2024
- DOMAIN THERAPEUTICS
- Stanislas MAYER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS
- Publication number 20240018125
- Publication date Jan 18, 2024
- ERMIUM THERAPEUTICS
- Jean-Philippe HERBEUVAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS
- Publication number 20220378772
- Publication date Dec 1, 2022
- DOMAIN THERAPEUTICS
- Anne-Laure BLAYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-HETEROARYL-PYRIDIN-2-AMINE COMPOUNDS AS NEUROPEPTIDE FF RECEPTOR...
- Publication number 20220298135
- Publication date Sep 22, 2022
- DOMAIN THERAPEUTICS
- Stephan SCHANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLINE DERIVATIVES AS CXCR4 MODULATORS
- Publication number 20220144853
- Publication date May 12, 2022
- UNIVERSITE DE PARIS
- Nassima BEKADDOUR BENATIA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALL...
- Publication number 20220089609
- Publication date Mar 24, 2022
- DOMAIN THERAPEUTICS
- Camille AMALRIC
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20210380606
- Publication date Dec 9, 2021
- Merck Patent GmbH
- Anne-Laure BLAYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20210361669
- Publication date Nov 25, 2021
- Merck Patent GmbH
- Anne-Laure BLAYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF GROU...
- Publication number 20200140438
- Publication date May 7, 2020
- Anne-Laure BLAYO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...
- Publication number 20190152979
- Publication date May 23, 2019
- DOMAIN THERAPEUTICS
- Stephan SCHANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TRICYCLIC 1,4-BENZODIAZEPINONE DERIVATIVES AS ALLOSTERI...
- Publication number 20180346468
- Publication date Dec 6, 2018
- Mavalon Therapeutics Limited
- Stephan SCHANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...
- Publication number 20170305913
- Publication date Oct 26, 2017
- DOMAIN THERAPEUTICS
- Stephan SCHANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...
- Publication number 20150105381
- Publication date Apr 16, 2015
- DOMAIN THERAPEUTICS
- Stanislas Mayer
- G01 - MEASURING TESTING
Information Patent Application
Novel Oxime Derivatives and Their Use As Allosteric Modulators of M...
- Publication number 20120277212
- Publication date Nov 1, 2012
- PRESTWICK CHEMICAL, INC.
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW ADENOSINE RECEPTOR LIGANDS AND USES THEREOF
- Publication number 20110288074
- Publication date Nov 24, 2011
- DOMAIN THERAPEUTICS
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODU...
- Publication number 20090093476
- Publication date Apr 9, 2009
- FAUST PHARMACEUTICALS
- Stephan Schann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Partial and full agonists of A1 adenosine receptors
- Publication number 20060052330
- Publication date Mar 9, 2006
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY

Stanislas Mayer

Person

Patents Grantslast 30 patents

5-azaindazole derivatives as adenosine receptor antagonists

Substituted heterocyclic compounds as allosteric modulators of grou...

Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteri...

Substituted pyrazoloquinazolinones and pyrroloquinazolinones as all...

Substituted pyrazoloquinazolinones and pyrroloquinazolinones as all...

Adenosine receptor ligands and uses thereof

Oxime derivatives and their use as allosteric modulators of metabot...

Partial and full agonists of A1 adenosine receptors

Patents Applicationslast 30 patents

5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

NOVEL PAR-2 INHIBITORS

CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS

PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS

5-HETEROARYL-PYRIDIN-2-AMINE COMPOUNDS AS NEUROPEPTIDE FF RECEPTOR...

IMIDAZOLINE DERIVATIVES AS CXCR4 MODULATORS

SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALL...

5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF GROU...

SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...

SUBSTITUTED TRICYCLIC 1,4-BENZODIAZEPINONE DERIVATIVES AS ALLOSTERI...

SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...

SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALL...

Novel Oxime Derivatives and Their Use As Allosteric Modulators of M...

NEW ADENOSINE RECEPTOR LIGANDS AND USES THEREOF

PYRROLO[1,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODU...

Partial and full agonists of A1 adenosine receptors